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Abstract
Purpose Evidence suggests that being physically active in
combination with a healthy diet contributes to diminish colo-
rectal cancer risk. However, if this is true for colorectal cancer
primary prevention, the same is not clear for its recurrence
after colorectal cancer treatments. Data on cancer survival
are scarce, and there is a need for greater attention on these
survivors’ lifestyle behavior. This manuscript describes ratio-
nale and design of the Cancer Survival Study (CASUS) on
colorectal patients, a longitudinal observational study with the
aim of investigating how physical activity, physical fitness,
and dietary intake are related with their quality of life, disease
recurrence, and survival.
Methods The CASUS on colorectal patients is a longitudinal
cohort study on colorectal survivors, aged 18 years or older,
recruited 6, 12, and 24 months after surgery. Upon recruitment,
patients fill in a battery of questionnaires about physical activ-
ity, dietary intake, and quality of life, donate blood samples, do
physical fitness tests, and use an accelerometer during 7 days.
Repeated analyses will be performed to assess changes over
time in physical activity, physical fitness, dietary intake, and
other factors in relation to recurrence and survival.
Conclusions Results will contribute to highlight the role of
physical activity, physical fitness, and nutrition in the quality
of life of colorectal cancer survivors, recurrence, and survival.
This studywill provide important information for policymakers
on the potential benefits of future physical activity and nutri-
tional interventions, which are inexpensive, as a way to im-
prove general health of colorectal cancer survivors.
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Background
Colorectal cancer (CRC) is one of the most common cancers,
representing nearly 10 % of the global cancer incidence [1]. In
Portugal, CRC incidence ranks second among all cancers, in
both men and women after prostate and breast cancers [2], with
5-year survival rates ranging from 50 to over 60 % [3]. An
increase in survival from CRC is expected, not only because
of better screening programs but also because treatments have
improved. Aging will also lead to a higher number of CRC
cases and consequently to a higher number of survivors.
Data on cancer survival are scarce, and there is a need for
greater attention on the lifestyle behavior of these survivors
[4], especially because cancer diagnosis might be a Bwindow
of opportunity^ for behavioral change [5]. In USA, more than
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half of patients with cancer die of noncancer causes, being
cardiovascular disease (CVD) one of the leading causes [4].
The CVD risk in cancer survivors results of both risk factors
and treatment side effects [6]. Physical inactivity and an un-
healthy diet that converge as cancer and CVD risk factors, and
may have contributed to CRC development in the first place,
are regarded as important behavioral targets [4, 6]. Thus, be-
sides survival, efforts should also start to be directed toward
improving the quality of life and health of cancer survivors.
With this goal in mind, physical activity (PA) and nutrition
might have substantial potential to ameliorate short-term and
long-term effects of cancer treatments such as fatigue, body fat
gain, and physical fitness (PF) loss, prevent the development
of other chronic diseases for which survivors might be at risk
such as diabetes and CVD, and to reduce the odds of a recur-
rence and increase survival.
CRC survivors experience symptoms and adverse effects
associated with their cancer and cancer treatment, such as
substantial physical and psychosocial impairment that may
endure for many years and negatively influence the health,
daily functioning, societal participation, and, thus, quality of
life of CRC survivors [7–10]. Cancer has the potential to dis-
turb all the aspects of an individual’s life; substantial levels of
fatigue, anxiety, depression, lower physical and social func-
tioning, chemotherapy-induced peripheral neuropathy, and so-
cial, economic, employment, and financial problems have
been reported after cancer diagnosis [10–12].
CRC is, as aforementioned, strongly linked to lifestyle fac-
tors, so it is reasonable to assume that those same factors will
be important in survivorship to prevent recurrence and to en-
hance health after cancer treatments. Evidence has been sug-
gesting that the high consumption of red and processed meat,
fat, and alcohol accompanied of a low vegetable and fruit
consumption as well as low levels of PA and a high bodymass
index all together may contribute to CRC development [13].
Carcinogenesis is a dynamic and complex process that be-
gins with an irreversible genetic alteration (initiation step)
[14]. Although the most widely exploited causes of DNA
damage are exogenous factors such as exposure to certain
chemicals, genetic alterations may also originate from the de-
cay of the primary structure of DNA, replication errors, and
damage due to normal oxidative metabolism and nonenzymat-
ic alkylation from endogeneous metabolites [15]. Actually,
cells are constantly exposed to oxidants from normal metabol-
ic reactions in the form of reactive oxygen and nitrogen spe-
cies [16]. These reactive oxygen species (ROS) are able to
oxidize DNA leading to the formation of oxidized bases and
single-strand and double-strand breaks. In order to limit the
levels of ROS present in cells and therefore the damage they
induce, the cell holds many defense mechanisms.
Nevertheless, if the production of ROS exceeds the body’s
natural antioxidant defense mechanisms, cell macromolecules
such as DNA, proteins, and lipids may be damaged [17].
Throughout the last years, different authors have demon-
strated that metabolism, exercise, and diet are determinants of
oxidative DNA damage, often indicated as a biomarker of
carcinogenesis [18].
The role of exercise on DNA damage levels seems to
depend on the intensity and duration of exercise. Different
studies show that intensive (anaerobic physical activity) ex-
ercise is based on increased metabolic rate and might thus
increase the rate of oxidative DNA [19], while regular ex-
ercise, with moderate intensity and duration, upregulates the
activity of DNA repair enzymes decreasing the oxidative
challenge to the body [20]. A recent study, conducted in
healthy individuals, has suggested that higher levels of usu-
al PA are associated with increased levels of DNA repair
and unrelated to DNA damage [21].
Diet is a relevant determinant of carcinogenesis as individ-
uals are exposed to a number of carcinogenic and anticarcino-
genic substances through edibles [22]. In the case of colon
cancer, risk is higher among subjects with dietary patterns
characterized by high consumption of red meat and lower
among those that predominately consume fruits and vegeta-
bles [23].
Deleterious nutritional habits may increase the formation of
reactive oxygen species in the intestinal lumen and continuous
exposure of the mucosa to these free radicals, which promote
oxidative damage to the DNA of the epithelial cells, thereby
triggering the appearance of genetic mutations [24].
Altogether, evidence suggests that the mechanism of ben-
efit from diet and physical activity concerns to energy balance,
with excess body weight being a risk factor, which is modifi-
able through lifestyle [25].
Considerably less is known about the role of PA, PF, and
eating habits during and after CRC treatments than for its
primary prevention [26]. Studies in CRC survivors measuring
PA directly, by using accelerometers, are scarce. Moreover,
PF, which is essential for daily tasks, has not been compre-
hensively studied in CRC survivors, and it is also considered
to be a very important health outcome and mortality predictor
[27]. Besides, there is a need of observational researches to
study the associations between PA, PF, and nutrition with
quality of life, disease recurrence, and survival by using bio-
logical markers, such as DNA damage, that might elucidate
mechanism of action, in cancer survivors [28]. Evidence-
based lifestyle recommendations are necessary, since the num-
ber of CRC survivors is increasing and is expected to rise in
the future.
The aim of this study is to uncover the associations of PA,
fitness, and nutrition among quality of life, disease recurrence,
and survival in CRC survivors by using a multiapproach. We
hypothesize that more physical active and fit patients have
higher quality of life, less disease recurrence, and higher sur-
vival and that a better dietary intake is related with less disease
recurrence and higher survival.
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Methods/design
The CASUS on colorectal patients is a prospective cohort
study on PA, fitness, nutrition, and its influences on quality
of life, disease recurrence, and survival. The ethics committee
of Centro Hospitalar São João, Porto, granted the ethical ap-
proval of the study (Porto, Portugal).
Recruitment
Men and women, above 18 years old, 6 months post-surgery
are invited to participate in the study. Stage I–III CRC patients
are enrolled and followed up until 2 years after the end of
treatment, with repeated measurements performed during
preplanned hospital visits at 6, 12, and 24 months post-sur-
gery. Additionally, survival will be assessed 5 years after di-
agnosis through medical records. Patients with hereditary co-
lorectal cancer disorders (Lynch syndrome, familial adenoma-
tous polyposis, and Peutz-Jeghers syndrome), dementia, or
another mental condition that makes them incapable to fill in
questionnaires properly are excluded from the study. Two gas-
troenterologists establish contact with the patients and do the
recruitment selection. Patients who agree to participate have to
provide written informed consent.
A recruitment rate of, approximately, eight CRC patients
per month is expected (100 new participants per year), and a
dropout rate of ∼20–25 % is expected at each time point.
Since, this study will has several exposures and outcomes,
the sample size for this cohort study is based on a relationship
of special interest: physical activity and its association with
quality of life. Thus, the sample size was based on the estimate
that only 5 % of cancer survivors are meeting recommenda-
tions for physical activity [29]. A sample size greater than 74
is required to obtain a 95% confidence interval and a power of
80 %. To allow for an expected 60 % response rate to the
questionnaire and a dropout rate of about 20–25 %, at least
126 questionnaires should be delivered.
Data collection
Participants are asked to fill in several questionnaires at 6, 12,
and 24months after surgery (Fig. 1). Additionally, patients are
asked to allow a blood sample collection at each time point.
Demographic and health characteristics
Demographic and health characteristics are evaluated with a
self-administered questionnaire, which contains questions on
demographics as education, ethnicity, family income per
month and occupation, smoking habits, and medication.
Additionally, treatment type and comorbidities are character-
ized through hospital records.
Health-related quality of life (HRQoL) is assessed with the
European Organization for the Research and Treatment of
Cancer Quality of Life Questionnaire-Core 30 (EORTC
QLQ-C30) [30]. This questionnaire incorporates five func-
tional scales (physical, role, cognitive, emotional, and social),
three symptom scales (fatigue, pain, and nausea and
vomiting), a global health status and a number of single items
assessing additional symptoms commonly reported by cancer
patients (dyspnea, loss of appetite, insomnia, constipation, and
diarrhea), and perceived financial impact of the disease [31].
This questionnaire is complemented by, a disease-specific
module, the CRC-specific CR29 module. Moreover, the
patient-reported chemotherapy-induced peripheral neuropa-
thy module (EORTC QLQ-CIPN20) is also used [32, 33].
This questionnaire includes three scales assessing sensory,
motor, and autonomic symptoms that can result from neurop-
athy [32, 33].
Health status is assessed with the Portuguese version of the
Short Form-36 (SF-36) questionnaire [34, 35]. The SF-36
consists of eight important concepts in health status: physical
function, emotional functioning, bodily pain, general health
perceptions, vitality, social function, and mental health [34,
35]. The subscales can be combined into the physical and
mental component summary scores. All scales will be linearly
converted to a 0–100 scale according to standard scoring pro-
cedures, with higher scores indicating better HRQoL.
Fatigue is assessed through the Checklist of Individual
Strength (CIS20-P) questionnaire [36]. The CIS20 items rep-
resent four dimensions of fatigue: subjective experience of
fatigue, concentration, motivation, and PA [36]. Higher scores
indicate higher levels of subjective experience of fatigue
(ranging from 8 to 56), reduced concentration (5–35), reduced
motivation (4–28), and lower levels of PA (3–21).
Furthermore, a total CIS20 score (fatigue severity) can be
calculated by adding up the scores from each dimension
(20–140) [36].
Work productivity and activity impairment questionnaire-
General Health (WPAI-GH v1.4) is used to measure work
productivity losses caused by health problems. The WPAI-
GH is composed of six questions that ask the subject if he is
currently employed, the number of nonworking hours due to
health problems, the number of nonworking hours due to oth-
er reasons (e.g., vacation), the number of hours really worked,
how the health problems affected his productivity while he
was working, and how the health problems affected his daily
activities over the last 7 days. The questions are computed
according to specific calculation rules and have four scores:
(1) percentage of work time missed due to health (absentee-
ism), (2) percentage of impairment at work due to health
(presenteeism), (3) percentage of overall work productivity
loss due to health (absenteeism and presenteeism), and (4)
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percentage of daily activity impairment outside of work due to
health. High scores indicate prolonged sick leave or impair-
ment and decreased productivity [37].
Physical activity and physical fitness
PA is assessed by International Physical Activity
Questionnaire (IPAQ) and with the use of accelerometer at
6, 12, and 24 months after surgery.
IPAQ short Blast week^ version is used. IPAQ reports sep-
arately vigorous-intensity PA, moderate-intensity PA, and
walking in terms of frequency and duration of each specific
type of activity, in the past 7 days. This instrument also reports
the time spent sitting in an ordinary weekday and weekend
day. Both categorical and continuous indicators of PA are
possible from the IPAQ short version. Validity and reliability
data from 12 countries (including Portugal) have showed that
IPAQ has comparable validity and reliability to CSA monitor
and to other self-report PA measures (Craig et al. 2003).
According to the guidelines for data processing and IPAQ
analysis (IPAQ, 2005), total PA can be expressed as MET
min/week (metabolic equivalent), by weighting the reported
minutes per week, in each activity category, by the metabolic
equivalent specific to each activity.
The Actigraph GT3M accelerometer (Manufacturing
Technology, Fort Walton Beach, FL) is used as an objective
measure of current daily PA for seven consecutive days.
Participants that agree to wear an accelerometer are instructed
to use it for seven consecutive days in their right hip by using
an adjustable nylon belt. Exceptions have included time spent
sleeping and showering. Participants are asked to maintain
usual activities. In order for the data to be included in the
analyses, participants will need to wear the accelerometer for
at least in 4 of the 7 days.
PF is assessed through the 6-min walk test (6MWT), a 30-s
chair-stand test (30sCST), and isometric handgrip strength
[38–40]. The 6MWT is performed over a 30-m course in an
undisturbed indoor corridor with the turnaround points
marked with a cone. Participants are instructed to walk back
and forth at their fastest pace covering as much distance as
possible during the allotted time. The testing course was stan-
dardized, and encouragement is given, and the time remaining
is called out every minute. The score is the total distance
walked in 6 min, measured in meters. Lower extremity muscle
strength is measured by using the 30sCST. Participants are
asked to sit in a 45-cm-high chair with arms crossed at the
wrists and held against the chest. Participants completed as
many Bstand ups^ as possible within 30 s. The score is the
total number of stands executed correctly within 30 s. Grip
strength is measured in kilograms in the dominant hand by
using a digital hand dynamometer (TKK 5401; Grip-D,
Tokyo, Japan) with the subjects in a standing position, with
the arms at their side and not touching the body throughout the
test. Subjects are instructed to grip maximally but to squeeze
only once for each measurement, and three maximal attempts
were recorded, with a 30-s rest in between.
Dietary intake
Dietary intake is assessed by a 7-day food record and a semi-
quantitative food frequency questionnaire (FFQ). This semi-
quantitative FFQ was validated for Portuguese adults [41, 14]
and designed in accordance with criteria laid out by Willett
and adapted to include a variety of typical Portuguese food
items [42]. The FFQ administrated at 6 months (baseline)
covers the previous 12 months before surgery. The FFQ in-
cludes 86 food item and beverage categories, and for each
item, the questionnaire offers nine frequency response op-
tions, ranging from Bnever^ to Bsix or more times per day,^
Quesonnaires 
6 months aer Surgery 
Accelerometer


















Fig. 1 Overview and design of the CASUS
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and measures portion size and seasonality. Any foods not
covered in the questionnaire are listed by participants in a
free-response section. Energy and nutritional intake are esti-
mated with regard to respondents’ frequency ratings, portion,
and seasonality of each item. Food record includes seven con-
secutive days (five weekdays and two weekend days) and is
completed by participants. Foods’ portion size and beverages
consumed are estimated by using household measures (cups,
glasses, spoons, slices, food wrappers or containers, etc.) as an
aid in determining serving sizes. A description of each food
and beverage consumed is recorded, including preparation
method, time (to the nearest 5 min), location, and if appropri-
ate the brand name of the product. Nutrient analysis means
that the 7 days will be used in the analysis. Nutrient analysis
will be performed by using the software Food Processor SQL
(ESHA Research Inc., Salem, OR, USA). This program uses
nutritional information from the USA that has been adapted
for use with typical Portuguese foods and beverages. The
intake of dietary supplements will also be evaluated through
interview on the use of multivitamin/minerals/vitamin supple-
ments and on the dosage and intake frequency.
Anthropometric measures
With participants wearing light clothing and without shoes,
body weight is assessed by using a Tanita Inner scan BC-
532 (Tanita, Hoofddorp, The Netherlands) to the nearest
0.10 kg. Stature is measured by using a stadiometer Seca
model 708 (Seca, Hamburg, Germany) to the nearest millime-
ter. Waist circumference (WC) is measured midway from the
lower rib margin to the anterior superior iliac crest by using a
nonmetallic tape without significant compression and record-
ed to 0.1 cm.
DNA damage
The comet assay is a rapid, simple, visual, and sensitive meth-
od assay that can detect DNA damage that is an underlying
molecular event driving the initiation and progression of can-
cer [43].
Briefly, individualized cells are embedded in agarose, lysed
with detergent to remove cell and nuclear membranes, and
treated with a high salt solution. Nucleoids are formed, con-
taining non-nucleosomal but still supercoiled DNA. Any
breaks present in the DNA cause the supercoiling to relax
locally, and loops of DNA are then free to extend toward the
anode during electrophoresis. At the end of this procedure,
damaged cells will resemble comets (hence the name comet
assay) while nondamaged cells maintain their round appear-
ance. Comets are viewed by fluorescence microscopy after
staining with a suitable fluorescent DNA-binding dye [44].
Throughout the years, there were several modifications and
innovations to the original protocol which led to an array of
comet assay variants that detect different types of DNA alter-
ations. Specific types of DNA lesions, related to oxidative
damage, can be measured by using lesion-specific repair en-
zymes [45].
To detect basal levels of DNA damage, we will run the
alkaline comet assay according to what has previously de-
scribed by Costa et al. [46]. In addition, the assay will also
be performed with an additional step of incubation with the
restriction enzymes formamidopyrimidine-DNA glycosylase
(FPG) and 8-oxoguanine DNA N-glycosylase 1 (hOGG1) to
detect oxidative damage. FPG is specific for oxidized purines,
including 8-oxo-7,8-dihydroguanine (8-oxoGua), 2,6-
diamino-4-hydroxy-5-formamidopyrimidine (FaPyGua), and
4,6-diamino-5-formamidopyrimidine, (FaPyAde) and other
ring-opened purines, whereas hOGG1 is specific for 8-
oxoGua and methyl FapyGua (MeFapyGua) [45].
The size and shape of the comet and the distribution of
DNAwithin the comet correlate with the extent of DNA dam-
age present in the individual cell. Images will be captured by
an online CCD camera and analyzed with the Comet Assay IV
analysis software (Perceptive Instruments). For each cell,
DNA damage will be expressed as the percentage of DNA
in the comet tail. A total of 100 cells are analyzed per sample,
50 per duplicate slide.
Recurrence and survival
According to the hospital internal protocol, for colorectal can-
cer, the follow-up is the following: A colonoscopy will be
done 3 months after surgery and then annually until 5 years
after diagnosis and then every 2 years; an ultrasound and
carcinoembryonic antigen (CAE) determination will be done
every 6 months. These results will be used to determine recur-
rence. Survival will be assessed throughout medical records.
Endpoints
The primary endpoints will be disease recurrence and death.
Secondary endpoint will be quality of life, fatigue, and work
productivity.
Nonparticipants and subjects lost in follow-up
Comparisons to determine whether demographic and/or
cancer-related characteristics were differed between partici-
pants and nonparticipants will be made. Additionally, compar-
isons between those who completed the baseline
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questionnaire and those who were lost to follow-up will be
made to determine possible differences.
Participants may withdraw from the study at anytime; in
these circumstances, we will use the already collected data
from those participants. Participants’ missing information
might be dealt with multiple imputations since imputation
adjusts for differences among nonrespondents and respon-
dents on existent variables for both and incorporated in the
imputation procedure, as well as differences on variables not
integrated in the model that are predicted by the model [47].
Statistical analysis will be done with and without the imputa-
tions to observe if results are maintained and reported in
results.
Conclusions
The CASUS on colorectal patients will critically assess im-
portant research questions, which may provide new leads for
future intervention studies and improved lifestyle counseling
strategies on CRC. This study will provide important infor-
mation for policymakers on the potential benefits of future PA
and nutritional interventions, which are inexpensive, as a way
to improve general health of CRC survivors.
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